The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE -/- FXR -/- Mice

Background: Farnesoid X receptor (FXR), a bile acid-activated nuclear receptor, is a potent regulator of glucose and lipid metabolism as well as of bile acid metabolism. Previous studies have demonstrated that FXR deficiency is associated with metabolic derangements, including atherosclerosis and no...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Endocrinology and metabolism (Seoul) 2021-12, Vol.36 (6), p.1243
Hauptverfasser:	Yenna Lee, Bo-rahm Kim, Geun-hyung Kang, Gwan Jae Lee, Young Joo Park, Haeryoung Kim, Hak Chul Jang, Sung Hee Choi
Format:	Artikel
Sprache:	kor
Schlagworte:	Apolipoproteins E Atherosclerosis FXR Non-alcoholic fatty liver disease Peroxisome proliferator-activated receptors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!